SMN1 and proximal spinal muscular atrophy: These include species-specific differences between humans and mice, which likely include discrepancies in typical/required SMN dosage, as well as the specific SMA mouse models utilized (as each express different SMN dosages most likely due to position effects of transgene integration sites and/or promoters used).